Status:
COMPLETED
Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
6-17 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and effectiveness of an herbal product for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Detailed Description
ADHD is a common childhood disorder associated with concentration problems and disruptive behavior. Evidence suggests that herbal remedies may be as effective as standard drug therapies in treating AD...
Eligibility Criteria
Inclusion
- Diagnosis of ADHD
- Score of greater than 1.5 standard deviation above the age and gender norms on the ADHD-IV rating scale
- Parents and children can understand English
- Parents and children willing to attend all study visits
- Able to swallow study medication
- Willing to use acceptable methods of contraception
Exclusion
- Severe depression
- History of bipolar disorder, psychosis, severe conduct disorder, or other serious medical conditions
- Use of medications that may interact with the herbal product
- Current use of medications to treat ADHD
- Previous use of Hypericum
- Pregnancy
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00100295
Start Date
February 1 2005
End Date
November 1 2006
Last Update
October 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bastyr University
Kenmore, Washington, United States, 98028